Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wound healing activity refers to the complex, multi-phase physiological process by which damaged tissue undergoes repair following injury. This process is orchestrated through four overlapping phases: hemostasis (cessation of bleeding), inflammation, proliferation (new tissue formation and re-epithelialization), and remodeling (scar formation and tissue strengthening). Each phase depends on coordinated actions of platelets, neutrophils, macrophages, fibroblasts, endothelial cells, keratinocytes, and a network of cytokines and growth factors. Therapeutic targeting of wound healing generally aims to accelerate or modulate these phases; however, "wound healing activity" is not a molecular target but an aggregate of underlying molecular and cellular events
Drugs enhance or inhibit different processes related to wound healing (e.g., promoting angiogenesis, stimulating fibroblast proliferation, modulating inflammation, antibacterial effects)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wound healing activity.